<?xml version="1.0" encoding="UTF-8"?>
<ref id="B24">
 <label>24.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Zhu</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Yu</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Yan</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Chong</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>He</surname>
    <given-names>Y.</given-names>
   </name>
  </person-group>
  <article-title>Design of potent membrane fusion inhibitors against SARS-CoV-2, an emerging coronavirus with high fusogenic activity.</article-title>
  <source>
   <italic>J Virol.</italic>
  </source> (
  <year>2020</year>) 
  <volume>94</volume>:
  <issue>e00635-20</issue>. 
  <pub-id pub-id-type="doi">10.1128/JVI.00635-20</pub-id>
  <?supplied-pmid 32376627?>
  <pub-id pub-id-type="pmid">32376627</pub-id>
 </mixed-citation>
</ref>
